PillRx only · Solution/ Drops · Ophthalmic
Sulfacetamide Sodium
Sulfacetamide Sodium
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.982
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
6
Active US suppliers
33%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
4.4K
Rx · 2026 Q1
66K
Units dispensed
-37%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Asclemed USA, Inc. | unknown | 1 | SUPPLYING |
| Proficient Rx LP | unknown | 1 | SUPPLYING |
| Bausch & Lomb Incorporated | unknown | 1 | SUPPLYING |
| A-S Medication Solutions | unknown | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Preferred Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.